新关注 > 信息聚合 > 普洛药业与上海药物研究所合作开发新药

普洛药业与上海药物研究所合作开发新药

Puluo pharmaceutical and Shanghai Pharmaceutical Research Institute of new drug development

2015-06-08 21:19:33来源: 东方财富网

普洛药业(000739)6月8日晚间公告,为推动公司业务由原料药向制剂化延伸发展,进而向创新药发展,公司全资子公司之全资子公司浙江巨泰药业有限公司与中科院上海药物研究所,就化药1.1类新药YG-00...

Puluo Pharmaceutical (000739) June 8th evening announcement, to promote the business of the company by the API to the formulation of the extension of the development and to the development of innovative drugs, a wholly owned subsidiary of the company, a wholly owned subsidiary of Zhejiang Jutai Pharmaceutical Co., Ltd. and Shanghai Institute of pharmaceutical research, drug 1.1 class new drug YG-00...